No catches, no fine print just unadulterated book loving, with your favourite books saved to your own digital bookshelf.
New members get entered into our monthly draw to win £100 to spend in your local bookshop Plus lots lots more…Find out more
See below for a selection of the latest books from Biomedical engineering category. Presented with a red border are the Biomedical engineering books that have been lovingly read and reviewed by the experts at Lovereading. With expert reading recommendations made by people with a passion for books and some unique features Lovereading will help you find great Biomedical engineering books and those from many more genres to read that will keep you inspired and entertained. And it's all free!
This encyclopedic reference provides exhaustive treatment of materials used in or on the human body, including collagen-based materials, ceramics, adhesives, membranes, coatings, films. Coverage is divided into two main sections, Materials and Applications, with two volumes devoted to each area. The work deals with important materials issues such as biocompatibility, tissue response, surface modification, controlled release, implant wear, and biodegradability. Exploring the varied applications, the contributors address bone repair, joint replacement, tissue response and growth, metal plates used in orthopedics, bone cements, and vascular, coronary, ocular, and dental applications.
This book discusses the principles, methods, and applications of immunogold-silver staining (IGSS) to biomedical areas. It focuses on the latest advances in the dynamic and progressive field of IGSS.
Advances in Materials Science and Implant Orthopedic Surgery brings together experts from major university hospitals, materials scientists specializing in bio-materials, and development engineers working for implant manufacturers to address such issues as: mechanisms of fixation; foreign-body immune response; generation and consequences of ionic and wear debris; materials selection, design and manufacturing schemes; and surgical techniques to maximize the safety and efficacy of the devices.
This volume reports on the progress of various research teams involved in the creation of a database which would contain all listed and documented EC biomedical research projects. A full inventory of the current 400 projects is provided.
The first Human Genome Analysis Programme (HGAP) was launched for the years 1990-1992. The aim of this programme has been to ensure a significant European contribution to the worldwide effort to map the human genome and, in the long term, to set a basis for support of European research activities in future wide-ranging medical applications. The implementation of the programme was through research centres, transnational research projects, training and studies on the ethical, social and legal aspects of human genome research. About 100 European institutes were involved in this programme, which played an important role in the establishment of a more balanced relationship with regard to ongoing activities in the United States. All final reports on HGAP, which now is continued as a separate sub-area on human genome analysis under BIOMED-I, are published in this book.
This volume is the third in a series entitled Advanced Methods of Physiological System Modeling and the fifth in a series of research volumes published by Plenum under the sponsorship of the Biomedical Simulations Resource (BMSR) at the Uni versity of Southern California in the context of dissemination activities supported by the Biomedical Research Technology Program of the National Center for Research Resources at the National Institutes of Health under Grant No. P41 RR-OI861. These volumes are edited by BMSR principal scientists and report on recent research de velopments in the area of physiological systems modeling, as well as on advanced methods for analysis of physiological signals and data. As in the previous two volumes of this series, the work reported herein is con cerned with the development of advanced modeling methodologies and their novel application to problems of biomedical interest, with emphasis on nonlinear aspects of physiological function. The term advanced methodologies is used to indicate that the scope of this work extends beyond the ordinary type of analysis, which is confined traditionally to the linear domain. As the importance of nonlinearities in understanding the complex mechanisms of physiological function is increasingly recognized, the need for effective and practical modeling methodologies that address the issue of nonlinear dynamics in life sciences becomes more and more pressing.
Bioelectric and Biomagnetic Fields: Theory and Applications in Electrocardiology begins with a general description of the development of extracellular bioelectric and biomagnetic fields and the methods used in their analysis and measurement. The most effective electrodynamic models and most modern approaches to topographical (synchronous multilead) measurements of the field are reviewed. The next section discusses the major approaches to analysis of the inverse problem with a detailed description of multipole technique applied to the bioelectric and biomagnetic fields measured on or near the body surface. Special emphasis is placed on the interrelationship between the electric and magnetic fields of the same bioelectric generator. The last section explains the new approaches to chronotopographical representation of the electrophysiological characteristics deduced from the parameters of the bioelectric generator. The text includes the most recent experimental protocols and results from studies in electro- and magnetocardiology and electro- and magnetoneurology.
Genetic engineering has already produced impressive results in biological research. The gene transfer and cloning methods are changing biotechnology into an innovative activity with potentially great impact on health care, on chemical, pharmaceutical and food industries, on the agricultural and the natural environment. It has thus attracted a great deal of attention from the public and regulatory authorities. There is a need to reconcile technological progress with safety assurance and civic acceptance. Technologies are regulated according to the inherent risk evaluated, through criteria based upon existing scientific evidence, new rigorous information, and/or records of safe applications and good performances. This should also apply to biotechnology. The title Scientific-Technical Backgrounds for Biotechnology Regulation is only intended to indicate that regulatory provisions for biotechnological activities should be in agreement and not in open contradiction with scientific knowledge and established technological experience.
Health care delivery, therapies and pharmaceuticals face major changes throughout the industrial world. As cost containment strategies are introduced by governments, as payers become more conscious and influential in their decisions about shaping therapies, and as consumers become more involved in directing their own health care, health care providers and pharmaceutical companies are being challenged to rethink the way they do business. This volume explores these changes and the potential responses. Parallel developments in health care delivery, information systems, pharmaceutical discovery and development are explored in Europe, the U.S. and Japan. Alternative futures or scenarios of health systems in 2010 summarize this diversity in the context of economic growth and economic hard times. This book explores the future of biomedical science by considering how the social, political and economic context in health care delivery and pharmaceutical industry will evolve. There is a slight chance that the future will be a successful extrapolation of the present, far more likely are scenarios which forecast major changes in the paradigms of medicine and health policy. The papers and scenarios in this book review that broader range of change.
Volume 1 discusses the problems inherent in allocating limited biomedical technologies: whose needs take precedence, what individual rights and responsibilities are involved, and when societal good justifies restricting individual good. Volume Two focuses on two substantive areas of biomedical policy beset by conflicts. Physicians, patients, and public officials are locked in new battles over whether and when life-extending technologies should be used or withdrawn. Meanwhile, researchers, government officials, and patients struggle to determine who will receive experimental medical treatment, and what procedures should be instituted to protect the recipients.
Despite the social and economic importance of biomedical and health research, it is only fairly recently that the European Community became involved in research and technological development in this research sector. The general goal of the programme is clearly to contribute to a better quality of life by improving health, and its distinctive feature is to strengthen European collaboration in order to achieve this goal. The ultimate goal of the biomedical engineering part of the programme has been to contribute to the improvement of the quality of health care, as well as to the containment of its costs. Health technology assessment has gained further importance in view of the completion of the internal market within the EC. Such assessment may provide essential information for decision making at all levels (i.e. political, health services, medical).